HCPCS code Q0249 — Tocilizumab for covid-19. Status: Active. Effective Jun 24, 2021. Source: CMS HCPCS Level II.

Q0249

Active

Tocilizumab for covid-19

Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jun 24, 2021
Code type: alphanumeric
OPPS Status: L — Influenza / pneumococcal vaccines

MUE — Medically Unlikely Edits

Maximum units of Q0249 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 1600
Practitioner Services 1600

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2021-Q2
    Tocilizumab for covid-19